Part of The Mesothelioma Center. Contact Us
Mesothelioma-Line.com.
Journal Articles on Mesothelioma: Cancer Information for Patients and Families

Ranpirnase - an antitumour ribonuclease: its potential role in malignant mesothelioma

Monday, March 27th, 2006.

Expert Opinion on Biological Therapy. April 2006, Vol. 6, No. 4, Pages 391-399. [Link]

Nick Pavlakis†1 & Nicholas J Vogelzang2

1Royal North Shore Hospital, Department of Medical Oncology, St Leonards, NSW 2065, Australia. pavlakis@med.usyd.edu.au

2Nevada Cancer Institute, 10000 W. Charleson Blvd, Suite 260, Las Vegas, NV 89135, USA. nvogelza@nvcancer.org

† Author for correspondence

Abstract

Ranpirnase (Onconase®) is a novel cytotoxic ribonuclease. In clinical development as a single agent in patients with malignant mesothelioma (MM), at 480 μg/m2 intravenously weekly, analysis of survival indicated prolonged periods of stable disease in Phase II trials and a potential survival benefit, compared with doxorubicin, in a small unpublished Phase III trial. In all clinical studies it has generally demonstrated a favourable safety profile except for easily controlled allergic reactions and dose modifications for renal impairment. Standard first-line treatment for MM has recently been established with an antifolate and cisplatin. At present, a Phase III trial of doxorubicin with or without ranpirnase is nearing completion in MM patients without prior chemotherapy or one prior chemotherapy regimen.

Glossary

therapy
any of the measures taken to treat a disease. Unproven therapy is any therapy that has not been scientifically tested and approved. Use of an unproven therapy instead of standard (proven) therapy is called alternative therapy. Some alternative therapies have dangerous or even life-threatening side effects. For others, the main danger is that a patient may lose the opportunity to benefit from standard therapy. Complementary therapy, on the other hand, refers to therapies used in addition to standard therapy. Some complementary therapies may help relieve certain symptoms of cancer, relieve side effects of standard cancer therapy, or improve a patient's sense of well-being. The ACS recommends that patients considering use of any alternative or complementary therapy discuss this with their health care team.
regimen
(rej-uh-men) a strict, regulated plan (such as diet, exercise, or other activity) designed to reach certain goals. In cancer treatment, a plan to treat cancer.
oncology
(on-call-o-jee) the branch of medicine concerned with the diagnosis and treatment of cancer.
cytotoxic
(site-o-tox-ik) toxic to cells; cell-killing.
chemotherapy
(key-mo-THER-uh-pee) treatment with drugs to destroy cancer cells. Chemotherapy is often used with surgery or radiation to treat cancer when the cancer has spread, when it has come back (recurred), or when there is a strong chance that it could recur.
cancer
malignancy; a group of diseases typified by abnormal, generally out-of-control, cell growth.
mesothelioma
a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on mesothelioma.

« Mesothelioma Line Main Page.

2 Responses to “Ranpirnase - an antitumour ribonuclease: its potential role in malignant mesothelioma”

Arthur commented on :

Good Day,

I urgently need your assistance please. My Father has been diagnosed with Mesothelioma. We are based in South Africa and would I like to know whom I can contact to get hold of the new drug Ranpirnase / Onconase. Can you please assist me with this.

Your urgent attention is highly appreciated

Many Thanks

Arthur Williams

033 3944255

083 2773729

Arthur.Williams@sizwegroup.co.za

Administrator commented on :

Arthur-

Onconase/Ranpirnase is manufactured by Alfacell. They should be your most direct source for information on getting the drug:

I hope your father has much success with treatment.

Best wishes,
Mesothelioma-Line Administrator

Leave a Reply

All comments are moderated to prevent blog spam and thus will not automatically nor immediately appear.